ArticleBritish journal of cancer2026

Comment on Wang et al. on furmonertinib plus bevacizumab in TKI-resistant leptomeningeal metastasis.

Yue Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.